Richard Oliver
About Richard Oliver
Richard Oliver is the Regional Medical Lead for Cardiovascular at Bristol Myers Squibb in Chicago, Illinois, with a diverse background in clinical and analytical roles within the healthcare industry.
Company
Richard Oliver is currently employed at Bristol Myers Squibb, where he serves as the Regional Medical Lead for Cardiovascular health. He has been with the company since November 2020 and operates out of Chicago, Illinois, United States. Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Richard Oliver holds the title of Regional Medical Lead - Cardiovascular at Bristol Myers Squibb. In this role, he concentrates on advancing cardiovascular health through innovative practices and strategies. His focus is on enhancing patient health outcomes in the cardiovascular domain.
Education and Expertise
Richard Oliver completed his medical studies at Universidad de Ciencias Médicas, where he achieved an M.D. with a specialization in Medical Clinical Sciences/Graduate Medical Studies. His extensive education underpins his expertise in the medical field, especially in cardiovascular health and clinical sciences.
Background
Richard Oliver has a diverse background in both clinical and analytical roles within the healthcare industry. Prior to his current role, he served as a Senior Clinical Analyst at HOUSECALL PHYSICIANS OF ILLINOIS, SC from 2019 to 2020. He also worked as a Clinical Assistant at the CHICAGO INSTITUTE FOR NEUROPATHIC PAIN: MICHAEL ROCK M.D. from 2018 to 2019. In addition, he has experience as a Member and Provider Support at Evolent Health and as an MN Health Insurance Program Representative and Analyst at the State of Minnesota. His professional journey highlights a blend of clinical and administrative expertise.
Achieving Cardiovascular Health Outcomes
In his role at Bristol Myers Squibb, Richard Oliver is committed to improving cardiovascular health outcomes through innovative medical practices. His work focuses on employing the latest medical research and technologies to benefit patients with cardiovascular conditions. His background in both public and private healthcare sectors supports his capability to drive meaningful improvements in patient care in a diverse range of settings.